hyperkalaemia - Articles and news items

FDA to re-review application for AstraZeneca’s hyperkalaemia treatment

Industry news / 18 October 2016 / Niamh Louise Marriott, Digital Content Producer

Hyperkalaemia (potassium levels > 5.0 mEq/L in the blood serum) occurs in patients with advanced chronic kidney disease and chronic heart failure…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+